234 related articles for article (PubMed ID: 37563849)
1. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
[TBL] [Abstract][Full Text] [Related]
4. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Younossi ZM; Ong JP; Takahashi H; Yilmaz Y; Eguc Hi Y; El Kassas M; Buti M; Diago M; Zheng MH; Fan JG; Yu ML; Wai-Sun Wong V; Alswat K; Chan WK; Mendez-Sanchez N; Burra P; Bugianesi E; Duseja AK; George J; Papatheodoridis GV; Saeed H; Castera L; Arrese M; Kugelmas M; Romero-Gomez M; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1456-e1468. PubMed ID: 34229038
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
Serfaty L
Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
[TBL] [Abstract][Full Text] [Related]
6. Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.
Bergqvist CJ; Skoien R; Horsfall L; Clouston AD; Jonsson JR; Powell EE
Intern Med J; 2013 Mar; 43(3):247-53. PubMed ID: 22646061
[TBL] [Abstract][Full Text] [Related]
7. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.
Iacob S; Ester C; Lita M; Ratziu V; Gheorghe L
J Gastrointestin Liver Dis; 2016 Jun; 25(2):183-9. PubMed ID: 27308649
[TBL] [Abstract][Full Text] [Related]
8. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
[TBL] [Abstract][Full Text] [Related]
9. Primary care practitioners survey of non-alcoholic fatty liver disease.
Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
[TBL] [Abstract][Full Text] [Related]
10. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
Polanco-Briceno S; Glass D; Stuntz M; Caze A
BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians.
Mari A; Omari S; Abu Baker F; Abu Much S; Said Ahmad H; Khoury T; Nseir W; Mahamid M
Minerva Gastroenterol Dietol; 2019 Dec; 65(4):255-258. PubMed ID: 31646850
[TBL] [Abstract][Full Text] [Related]
12. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM; Alqahtani SA; Alswat K; Yilmaz Y; Keklikkiran C; Funuyet-Salas J; Romero-Gómez M; Fan JG; Zheng MH; El-Kassas M; Castera L; Liu CJ; Wai-Sun Wong V; Zelber-Sagi S; Allen AM; Lam B; Treeprasertsuk S; Hameed S; Takahashi H; Kawaguchi T; Schattenberg JM; Duseja A; Newsome PN; Francque S; Spearman CW; Castellanos Fernández MI; Burra P; Roberts SK; Chan WK; Arrese M; Silva M; Rinella M; Singal AK; Gordon S; Fuchs M; Alkhouri N; Cusi K; Loomba R; Ranagan J; Eskridge W; Kautz A; Ong JP; Kugelmas M; Eguchi Y; Diago M; Yu ML; Gerber L; Fornaresio L; Nader F; Henry L; Racila A; Golabi P; Stepanova M; Carrieri P; Lazarus JV;
J Hepatol; 2024 Mar; 80(3):419-430. PubMed ID: 37984709
[TBL] [Abstract][Full Text] [Related]
13. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
Wessels DH; Rosenberg Z
World J Hepatol; 2021 Feb; 13(2):233-241. PubMed ID: 33708352
[TBL] [Abstract][Full Text] [Related]
14. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions.
Anstee QM; Hallsworth K; Lynch N; Hauvespre A; Mansour E; Kozma S; Marino JP; Bottomley J; Piercy J; Higgins V
JHEP Rep; 2022 Jan; 4(1):100411. PubMed ID: 34977520
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment.
Lazure P; Tomlinson JW; Kowdley KV; Magni P; Santos RD; Jacobs G; Murray S
Liver Int; 2022 Aug; 42(8):1772-1782. PubMed ID: 35635757
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional pilot study to assess primary healthcare workers' knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico.
Vidal-Cevallos P; Ordóñez-Vázquez AL; Procopio-Mosso O; Cardoso-Arias R; Uribe M; Chávez-Tapia NC
Sci Rep; 2021 Jun; 11(1):12100. PubMed ID: 34103552
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
[TBL] [Abstract][Full Text] [Related]
18. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Younossi ZM; Golabi P; de Avila L; Paik JM; Srishord M; Fukui N; Qiu Y; Burns L; Afendy A; Nader F
J Hepatol; 2019 Oct; 71(4):793-801. PubMed ID: 31279902
[TBL] [Abstract][Full Text] [Related]
19. Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease.
Arab JP; Dirchwolf M; Álvares-da-Silva MR; Barrera F; Benítez C; Castellanos-Fernandez M; Castro-Narro G; Chavez-Tapia N; Chiodi D; Cotrim H; Cusi K; de Oliveira CPMS; Díaz J; Fassio E; Gerona S; Girala M; Hernandez N; Marciano S; Masson W; Méndez-Sánchez N; Leite N; Lozano A; Padilla M; Panduro A; Paraná R; Parise E; Perez M; Poniachik J; Restrepo JC; Ruf A; Silva M; Tagle M; Tapias M; Torres K; Vilar-Gomez E; Costa Gil JE; Gadano A; Arrese M
Ann Hepatol; 2020; 19(6):674-690. PubMed ID: 33031970
[TBL] [Abstract][Full Text] [Related]
20. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.
Quek J; Chan KE; Wong ZY; Tan C; Tan B; Lim WH; Tan DJH; Tang ASP; Tay P; Xiao J; Yong JN; Zeng RW; Chew NWS; Nah B; Kulkarni A; Siddiqui MS; Dan YY; Wong VW; Sanyal AJ; Noureddin M; Muthiah M; Ng CH
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):20-30. PubMed ID: 36400097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
